Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.

Simulations Plus, in partnership with the University of Connecticut, was awarded a new FDA grant to investigate additional ...

Collaboration Revenue - Collaboration revenue was $1.1 million for the quarter ended September 30, 2024, compared to $2.5 ...

The team’s in vitro, cell-based experiments found that in the presence of these muscle ... by leveraging established tools for in vivo biochemical stimulation and mechanotherapy, we hope our in vitro ...

In an in-vivo experiment, the researchers created a lesion cavity to ... One month later, observations of the in-vitro platform revealed an increase in neural activity -- with the growth of both ...

BDC-4182 has advanced into IND-enabling activities, supported by in vitro and in vivo experiments demonstrating potent anti-tumor activity in multiple preclinical models, with clinical trial ...

The findings add to a growing body of evidence suggesting that flavoring additives in vaping solutions may heighten health risks. New research suggests that berry-flavored vapes can compromise the ...

Praxis recognized $0.3 million in collaboration revenue during the three months ended September 30, 2024, compared to $0.5 million during the three months ended September 30, 2023. The decrease of ...

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 ...

Skeletal stem cells have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of ...

In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma (HCC), a recent study has identified a pivotal role for CD39 expression in ...